70% Returns In 12 Months: Dividend Paying Penny Stock Rises On Conversion Of Warrants; Do You Own?

The shares of Vikas Lifecare Limited witnessed a rise of over 1%, trading at Rs 5.07 per share on the Bombay Stock Exchange (BSE) as of 12:40 pm. This positive movement came on the back of the company's board approving the conversion of warrants into equity shares.

In a regulatory filing dated June 11, 2024, Vikas Lifecare announced, "In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in their meeting held today i.e., Saturday, June 11, 2024, considered and approved the allotment of equity shares on conversion of 1,28,00,000 warrants into 1,28,00,000 equity shares of the face value of Re. 1/- each at an issue price of Rs. 4/- each (including a premium of Rs. 3/- each), to 'Promoters' and 'Non-Promoters, Public Category', on a preferential basis, upon receipt of the balance amount aggregating to Rs. 3,84,00,000/- (Rupees Three Crores and Eighty-Four Lakhs Only) at the rate of Rs. 3/- (Rupees Three only) per warrant (being 75% of the issue price per warrant) from the allottees pursuant to the exercise of their rights of conversion into equity shares in accordance with the provisions of SEBI (ICDR) Regulations, 2018."

This move comes after a previous approval for the conversion of 2.30 crore warrants into equity shares, with the issue price set at Rs 4 per share. The company received Rs 6.9 crore from promoters and non-promoters, facilitating the conversion. With these conversions, the company's issued and paid-up capital now stands at Rs 182,31,68,560/-, consisting of 182,31,68,560 equity shares of Re. 1/- each. The newly allotted shares will rank pari-passu with existing equity shares, ensuring uniformity in shareholder rights and dividends.

Vikas Lifecare's market performance has been notable over the past year. The company, with a market capitalization of approximately Rs 904 crore, has seen its shares reach a 52-week high of Rs 7.92 and a low of Rs 3.01. Investors have enjoyed returns of nearly 70% over the past year, with a three-year return of about 52%. The stock has recovered more than 68% from its 52-week low of Rs 3.01 hit on July 31, 2023.

Adding to its dynamic corporate strategy, Vikas Lifecare recently announced a significant acquisition plan. The company has submitted a proposal to its independent director to acquire 100% equity in the American firm, Ebix Inc. This acquisition is poised to be executed under Chapter 11 of the US Bankruptcy Code, contingent on successful negotiations between Iraya Life Space Limited, Ebix, and other major stakeholders. Initially, 5% of the purchase amount will be deposited in cash.

Vikas Lifecare's participation in the consortium aiming to acquire Ebix Inc. further underscores its expansion strategy. The consortium, led by Iraya Life Space Limited, includes several companies collectively bidding for a complete takeover. The acquisition of Ebix Inc. reflects Vikas Lifecare's intent to diversify and strengthen its market position internationally.

Vikas Lifecare's journey has been marked by strategic financial decisions and business diversification. The company last issued rights shares in 2021, in a 4:21 ratio at a premium of Rs 2.00 per share. The share has been quoting ex-rights since October 29, 2021.

Originally engaged in the manufacturing and trading of polymer and rubber compounds and specialty additives for plastics, synthetic, and natural rubber, Vikas Lifecare has recently expanded its business interests. The company has ventured into the B2C segment, diversifying beyond raw materials to include consumer-facing products, thus broadening its market reach and revenue streams.

The conversion of warrants into equity shares and the potential acquisition of Ebix Inc. position Vikas Lifecare for sustained growth. The company's moves in financial structuring and market expansion reflect a robust vision for the future. By capitalizing on both domestic opportunities and international acquisitions, Vikas Lifecare is poised to enhance shareholder value and solidify its market presence.